Shenqiang Gao1, Yuelan Wang2, Jun Zhao3, Aiping Su4. 1. Department of Anesthesiology, Qianfo Mountain Hospital of Shandong University Jinan 250014, China ; Department of Anesthesiology, Taian Central Hospital Taian 271000, China. 2. Department of Anesthesiology, Qianfo Mountain Hospital of Shandong University Jinan 250014, China. 3. Department of Neurology, Taian Central Hospital Taian 271000, China. 4. Department of Nephrology, Mount Tai Hospital of Shandong Province Taian 271000, China.
Abstract
PURPOSE: This study aimed to explore effects of dexmedetomidine pretreatment on heme oxygenase-1 (HO-1) expression and oxidative stress during one-lung ventilation (OLV) in lung cancer patients. METHODS:Fifty patients with lung carcinoma (ASA I-II, 40-65 years old, body mass index [BMI]<30 kg/m2) undergoing pulmonary lobectomy were enrolled. They were divided randomly into two equal groups before anaesthesia induction to receive either intravenous injection of 1 μg/kg dexmedetomidine for 20 min (Dexmedetomidine) or not (Control). RESULTS: The results showed no difference in heart rate (HR), mean arterial pressure (MAP) and bispectral index (BIS) between the two groups, as well as liquid intake and output volume (LIO), duration of OLV and time from surgery beginning to excision of pathological tissues (P>0.05). Levels of tumor necrosis factor (TNF-α) and malondialdehyde (MDA) in Dexmedetomidine group were lower than that of Control at OLV 60 and 90 (P<0.05). Superoxide dismutase (SOD) activity and the expression level of HO-1 were higher in Dexmedetomidine group than in Control (P<0.05). CONCLUSIONS:Dexmedetomidine pretreatment could upregulated expression of HO-1 in lung tissue and reduce oxidative stress and inflammation during OLV. Thus dexmedetomidine played a role in protecting lung injury by promoting HO-1 expression.
RCT Entities:
PURPOSE: This study aimed to explore effects of dexmedetomidine pretreatment on heme oxygenase-1 (HO-1) expression and oxidative stress during one-lung ventilation (OLV) in lung cancerpatients. METHODS: Fifty patients with lung carcinoma (ASA I-II, 40-65 years old, body mass index [BMI]<30 kg/m2) undergoing pulmonary lobectomy were enrolled. They were divided randomly into two equal groups before anaesthesia induction to receive either intravenous injection of 1 μg/kg dexmedetomidine for 20 min (Dexmedetomidine) or not (Control). RESULTS: The results showed no difference in heart rate (HR), mean arterial pressure (MAP) and bispectral index (BIS) between the two groups, as well as liquid intake and output volume (LIO), duration of OLV and time from surgery beginning to excision of pathological tissues (P>0.05). Levels of tumor necrosis factor (TNF-α) and malondialdehyde (MDA) in Dexmedetomidine group were lower than that of Control at OLV 60 and 90 (P<0.05). Superoxide dismutase (SOD) activity and the expression level of HO-1 were higher in Dexmedetomidine group than in Control (P<0.05). CONCLUSIONS:Dexmedetomidine pretreatment could upregulated expression of HO-1 in lung tissue and reduce oxidative stress and inflammation during OLV. Thus dexmedetomidine played a role in protecting lung injury by promoting HO-1 expression.
Authors: Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala Journal: JAMA Date: 2012-03-21 Impact factor: 56.272
Authors: H Bruunsgaard; K Andersen-Ranberg; B Jeune; A N Pedersen; P Skinhøj; B K Pedersen Journal: J Gerontol A Biol Sci Med Sci Date: 1999-07 Impact factor: 6.053
Authors: Jianteng Gu; Pamela Sun; Hailin Zhao; Helena R Watts; Robert D Sanders; Niccolo Terrando; Peiyuan Xia; Mervyn Maze; Daqing Ma Journal: Crit Care Date: 2011-06-24 Impact factor: 9.097
Authors: Stefan Hofer; Jochen Steppan; Tanja Wagner; Benjamin Funke; Christoph Lichtenstern; Eike Martin; Bernhard M Graf; Angelika Bierhaus; Markus A Weigand Journal: Crit Care Date: 2009-02-06 Impact factor: 9.097
Authors: O Piazza; R I Staiano; E De Robertis; G Conti; V Di Crescenzo; S Loffredo; G Marone; G Zito Marinosci; M M Cataldi Journal: Transl Med UniSa Date: 2016-11-01